
Research Roundup: October 29, 2021
Research Roundup: October 29, 2021 Click here to view original post… […]
Research Roundup: October 29, 2021 Click here to view original post… […]
Harvard Chan School’s Kizzmekia Corbett has been named a “Federal Employee of the Year” for conducting groundbreaking vaccine research while working at the National Institutes of Health. Click here to view original post… […]
Harvard Chan School’s Asaf Bitton offered advice on choosing a COVID-19 vaccine booster. Click here to view original post… […]
Two more life sciences companies have made their Nasdaq debuts as IPOs ramp up following a summer lull. Click here to view original post… […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna Announces Additional Supply for Q2 2022 of Vaccine for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries Click here to view original post… […]
CAMBRIDGE, Mass.: CAMBRIDGE, Mass., Oct. 29, 2021 /PRNewswire/ — Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney disease, and its collaborator, Otsuka Pharmaceutical Co., Ltd. (Otsuka), today announced that Otsuka Pharmaceutical Netherlands B.V. has submitted an initial marketing… Click here to view original post… […]
Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here. The busy IPO season shows no sign of slowing, with three more biotechs trick-or-treating for their own stock tickers and some sweet raises Thursday. Entrada Therapeutics, Biofrontera Inc. and Aura Biosciences — all… Click here to view original post… […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Friday, November 5, 2021 to report its third quarter 2021 financial results and provide a… Click here to view original post… […]
WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen Reports Recent Progress and Third Quarter 2021 Financial Results Click here to view original post… […]
John Maraganore The departure of a number of CEOs is the prevailing theme that kicks off this week’s installment: In a stunner, Alnylam CEO John Maraganore announced that Yvonne Greenstreet will be his successor at the end of the year. Maraganore, the Cambridge, MA biotech’s… Click here to view original post… […]
Copyright © 2022 Biotech Networks, LLC